Regulatory and compliance requirements for a private label bakuchiol serum vary significantly by region and depend on whether bakuchiol is classified as a cosmetic active or a drug ingredient, which determines what claims you can make, what testing you must complete, and what documentation you must file. In the United States, bakuchiol is classified as a cosmetic ingredient (it is not an FDA-approved drug or over-the-counter monograph ingredient like salicylic acid or benzoyl peroxide), which means your serum can be marketed with cosmetic claims ("visibly reduces fine lines," "improves skin texture," "brightens complexion") but not drug claims ("treats wrinkles," "corrects aging skin," "heals damaged collagen"). The difference is semantic but legally critical: cosmetic claims describe benefits that occur within normal use, whereas drug claims imply a therapeutic intent to diagnose, cure, mitigate, treat, or prevent disease. If the FDA interprets your claims as drug claims, your serum becomes a drug, which then requires pre-market FDA approval (which is almost never pursued for cosmetics and would delay your launch indefinitely). Before launch, you must register your manufacturing facility with the FDA (if you are manufacturing in the US), file a Cosmetic Facility Report (CFR) every two years (this changed under MoCRA, the Modernization of Cosmetics Regulation Act, which took effect in November 2023), and maintain detailed batch records for each production run including ingredient sourcing, manufacturing dates, QC results, and any adverse event reports.
In the European Union, bakuchiol is regulated under the EU Cosmetics Regulation (EC 1223/2009), and while bakuchiol extract is allowed as a cosmetic ingredient, it is not listed on the EU Positive List of approved actives—it falls under the general prohibition on substances not explicitly permitted, but is permitted if it is considered safe under normal use conditions and supported by a safety assessment. This means your co-packer or a compliance consultant must conduct or obtain a safety assessment from a cosmetic toxicologist (typically a PDF document evaluating dermal irritation, sensitization, photostability, and microbiological safety) before you can legally sell the serum in the EU. You must also declare your product to the Cosmetics Product Notification Portal (CPNP), which catalogs all cosmetics sold in the EU; this is a one-time online filing that lists your formula, ingredients, and any intended use warnings. EU regulations also prohibit many preservatives common in the US (such as methylparaben and propylparaben in concentrations above 0.4% in leave-on products), so if you are launching in both markets, you may need two formulations—one for the US (typically with a full paraben system or phenoxyethanol) and one for the EU (with paraben-free or restricted preservatives).
In the United Kingdom (post-Brexit), bakuchiol serums are regulated under the UK Cosmetics Regulations 2022, which largely mirrors the EU framework. You must declare your product to the UK Cosmetics Products Enforcement Liaison Group (CPEL), and your formula must comply with UK approved ingredient restrictions (which are similar to but not identical to the EU list). If you are selling in multiple regions (US, EU, UK, Canada, Australia), you will need separate safety assessments for each region because regulatory thresholds for preservatives, UV filters, and colorants differ. For example, a preservative system acceptable in the US may exceed European limits, or an ingredient allowed in the US may be restricted in Australia.
Before or during production, consider commissioning a stability testing protocol to support your product shelf life claim. While not legally mandatory in all regions (the US does not require pre-market stability data for cosmetics), many retailers, e-commerce platforms, and savvy consumers will ask for evidence that your serum remains safe and effective for 12–24 months at room temperature or in realistic storage conditions (bathroom shelf, air-conditioned car). A standard approach is an accelerated stability test (8–12 weeks at 40 °C / 75% relative humidity) which correlates to several months of real-world stability, or a real-time test conducted over 3–6 months in a standard warehouse or home environment. Your co-packer may include a basic viscosity and color spot-check (a simple pass/fail visual assessment) in their standard QC, but a full stability report issued by an independent lab typically costs $400–800 and is worth the investment if you plan to make a "stable for 24 months" claim or if you are selling in regulated markets like Canada (which increasingly expects substantiation for shelf-life claims).
Bakuchiol serum labeling must comply with ingredient disclosure and warning label rules. In the US, you must list all ingredients in descending order of concentration on the label using INCI (International Nomenclature of Cosmetic Ingredients) names; the FDA does not pre-approve ingredient lists, but you must ensure all ingredients are compliant (this means checking that bakuchiol extract is recognized as a cosmetic ingredient, that your preservatives and colorants are approved, and that you have not included any banned substances). If your serum contains a sunscreen ingredient, it crosses into OTC drug territory and requires additional labeling and testing. In the EU, you must also list ingredients in INCI format, and you must include warnings or precautions if your formula contains fragrance allergens (limonene, eugenol, etc.), preservatives that trigger sensitivities (phenoxyethanol, methylisothiazolinone), or if the product is not suitable for children. Many brands also voluntarily include "Hypoallergenic," "Dermatologist-tested," or "Cruelty-free" claims, which may require third-party certification or supporting data depending on how the claim is worded.
If you are sourcing bakuchiol extract from a third-party supplier, ask for a Certificate of Analysis (CoA) that verifies the bakuchiol content (typically by HPLC), confirms that the extract is free of heavy metals, microbial contaminants (bacteria, molds), and pesticide residues, and states the botanical source (Babchi plant, Psoralea corylifolia, or synthetic bakuchiol depending on your brand positioning). Synthetic bakuchiol is chemically identical to plant-derived bakuchiol and is more stable and less prone to contamination, but indie brands often prefer plant-derived to align with natural or botanical positioning. Your co-packer should verify the CoA before incorporating the ingredient and can help you identify red flags (e.g., an extract with very high heavy metal levels or no microbial test results).
The most common mistake first-timers make is conflating cosmetic and drug claims and inadvertently using language that triggers regulatory concern. Phrases like "treats wrinkles," "reduces aging," "repairs skin," "corrects damage," or "heals collagen" are drug claims; safer alternatives are "visibly reduces the appearance of fine lines," "helps minimize wrinkles," "promotes smoother skin texture," or "supports skin elasticity." Also, do not invent testing or make claims unsupported by evidence (e.g., claiming "clinically proven to reduce wrinkles by 50%" without a published clinical study). Some brands commission third-party clinical studies (typically $8,000–15,000 for a small consumer perception or instrumental measurement study), but this is optional and not required by law. Finally, if you are launching in multiple regions, consult with a cosmetic regulatory specialist early (not after you have already formulated and produced inventory); a 30-minute consultation costs $200–400 and could save you thousands in reformulation or product recalls. Many vetted cosmetic chemists on AJ Cosmo Labs have regulatory expertise or can refer you to a compliant specialist.
Ingredients in this answer: Salicylic Acid · Bakuchiol · Phenoxyethanol
Read the full guide on Private Label Bakuchiol Serum Manufacturer Low MOQ Guide →